What is the latest FISCHER stock price?
The latest stored price for FISCHER is Rs 24.63 as of 2026-11-03.
gimli
FISCHER stock AI analysis
FISCHER Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
FISCHER MEDICAL VENTURE L is a small-cap stock in Healthcare. This Gimli page shows the latest available FISCHER price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹24.63
1W return
-3.56%
1M return
-26.39%
3M return
-36.31%
6M return
-35.12%
1Y return
-77.00%
Market cap
₹1,612.07 cr
PE
54.10
PB
4.19
ROE
+8.24%
ROCE
+7.55%
RSI
31.57
Turnover
₹1.38 cr
Why it can matter in screens
- Momentum: FISCHER is below 50DMA, below 200DMA; RSI is 31.57.
- Returns: 1D -0.12%, 1W -3.56%, 1M -26.39%, 3M -36.31%, 1Y -77.00%.
- Trend levels: 52W high ₹42.37, 52W low ₹21.78, off high -41.87%.
- Liquidity: latest turnover is ₹1.38 cr; volume vs 20D is +0.36%.
- Valuation/profitability: PE 54.10, PB 4.19, ROE +8.24%, ROCE +7.55%.
- Growth: 3Y sales CAGR +1096.15%, 3Y profit CAGR n/a.
Quick Answers
Is FISCHER above its 50DMA and 200DMA?
FISCHER is below 50DMA, below 200DMA. The latest 50DMA is 32.14 and the latest 200DMA is 36.37.
What are FISCHER PE, ROE and ROCE?
FISCHER has PE 54.10, ROE +8.24%, and ROCE +7.55% in Gimli's latest available snapshot.
How has FISCHER performed recently?
FISCHER has returned -26.39% over 1 month, -36.31% over 3 months, and -77.00% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 81.92 cr | 12.74 cr | 3.79 cr | 0.06 |
| 2026-03-31 | 97.73 cr | 2.27 cr | -7.12 cr | -0.11 |
| 2025-12-31 | 101.10 cr | 22.60 cr | 19.23 cr | 0.30 |
| 2025-09-30 | 88.79 cr | 18.73 cr | 13.90 cr | 0.21 |
| 2025-06-30 | 23.44 cr | 11.61 cr | 5.01 cr | 0.01 |
| 2025-03-31 | 49.17 cr | 2.55 cr | 1.31 cr | 0.01 |
| 2024-12-31 | 11.75 cr | 0.75 cr | -0.29 cr | -0.01 |
| 2024-09-30 | 39.66 cr | 0.55 cr | 0.29 cr | 0.05 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 308.58 cr | 55.18 cr | 31.02 cr | 0.48 |
| 2025-03-31 | 110.70 cr | 4.32 cr | 1.21 cr | 0.02 |
| 2024-03-31 | 20.98 cr | 2.36 cr | 1.84 cr | 1.65 |
| 2023-03-31 | 0.18 cr | 0.02 cr | -0.04 cr | -2.12 |
| 2022-03-31 | 0.00 cr | -0.19 cr | -0.23 cr | -1.35 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 671.01 cr | 11.89 cr | 107.08 cr | 385.14 cr |
| 2025-03-31 | 457.37 cr | 104.26 cr | 85.37 cr | 337.87 cr |
| 2024-03-31 | 86.32 cr | 0.95 cr | 1.68 cr | 81.11 cr |
| 2023-03-31 | 0.35 cr | 0.04 cr | 0.57 cr | -0.27 cr |
| 2022-03-31 | 0.19 cr | 0.02 cr | 0.39 cr | -0.23 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | -101.27 cr | -102.58 cr | n/a |
| 2025-03-31 | -86.25 cr | -92.24 cr | n/a |
| 2024-03-31 | -7.35 cr | -7.84 cr | n/a |
| 2023-03-31 | -0.15 cr | -0.15 cr | n/a |
| 2022-03-31 | -0.18 cr | -0.18 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +62.15% | +5.48% | +1.35% | +0.00% | +31.02% | +7.38% |
| 2026-03-31 | +62.15% | +4.97% | +1.38% | +0.00% | +31.50% | +7.38% |
| 2025-12-31 | +61.80% | +4.85% | +1.36% | +0.00% | +31.99% | +0.00% |
| 2025-09-30 | +61.80% | +5.57% | +1.42% | +0.00% | +31.21% | +0.00% |
| 2025-09-12 | +61.80% | +5.61% | +1.42% | +0.00% | +31.18% | +0.00% |
| 2025-07-09 | +61.80% | +5.55% | +1.42% | +0.00% | +31.23% | +0.00% |
| 2025-06-30 | +61.80% | +5.55% | +1.42% | +0.00% | +31.23% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze FISCHER MEDICAL VENTURE L with valuation, momentum and industry peers
- Compare FISCHER with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare FISCHER with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.